Cargando…
Mapping Bromodomains in breast cancer and association with clinical outcome
A specific family of proteins that participate in epigenetic regulation is the bromodomain (BRD) family of proteins. In this work, we aimed to explore the expression of the BRD family at a transcriptomic level in breast cancer, and its association with patient survival. mRNA level data from normal b...
Autores principales: | Pérez-Pena, Javier, Páez, Raquel, Nieto-Jiménez, Cristina, Sánchez, Verónica Corrales, Galan-Moya, Eva M., Pandiella, Atanasio, Győrffy, Balázs, Ocana, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450889/ https://www.ncbi.nlm.nih.gov/pubmed/30952871 http://dx.doi.org/10.1038/s41598-019-41934-3 |
Ejemplares similares
-
Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors
por: Nieto-Jiménez, Cristina, et al.
Publicado: (2017) -
DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer
por: Nieto-Jiménez, Cristina, et al.
Publicado: (2016) -
Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors
por: Pérez-Peña, Javier, et al.
Publicado: (2017) -
Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple‐negative breast cancer
por: Corrales‐Sánchez, Verónica, et al.
Publicado: (2020) -
Transcriptome evolution from breast epithelial cells to basal-like tumors
por: Santpere, Gabriel, et al.
Publicado: (2017)